New Kura Oncology Share‑Sale Filings Show Officer Sales, No Market ImpactSee how Kura Oncology’s latest 2026 share‑sale filings reveal routine officer activity and new institutional holdings, yet no market‑impact shifts.KURA ONCOLOGY INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 18/11/2026, 18:04 2 minutes to read